News from biologics prescribers collaborative A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Sep 11, 2017, 17:58 ET Physician Groups Urge CMS to Adopt Unique Billing Codes for Biosimilar Reimbursement Policy

Today, the Biologics Prescribers Collaborative (BPC) and five other groups representing a broad spectrum of physicians who prescribe biologics, urged ...


May 22, 2017, 05:32 ET Physician Groups Applaud FDA for Thoughtful Draft Guidance on Interchangeability, Urge for Robust Data to Demonstrate Biosimilarity

Biologics Prescribers Collaborative (BPC) applauds the U.S. Food and Drug Administration (FDA) for its careful consideration of interchangeability in ...


Jan 13, 2017, 04:35 ET Physician Groups Applaud FDA for Distinguishable Biologics Naming; Disappointed in 'Random' Suffix That Could Weaken Achievement

Biologics Prescribers Collaborative (BPC) applauds the U.S. Food and Drug Administration (FDA) for issuing final guidance calling for distinguishable ...


Aug 02, 2016, 04:07 ET Physician Groups Applaud FDA on Biosimilar Labeling, Urge For Greater Transparency To Ensure Patient Safety

On Tuesday, August 2, 2016, eight groups representing a broad spectrum of biologic prescribers – Alliance for Patient Access, American Association of ...


Jun 13, 2016, 02:19 ET Physician Groups Support Bill Providing Authority to FDA on Biologics

On Monday, June 13, 2016, six groups representing a broad spectrum of biologic prescribers – Alliance for Patient Access, American Association of...


Feb 09, 2016, 07:17 ET BPC Statement on FDA Arthritis Advisory Committee Meeting

On Tuesday, February 9th, the U.S. Food and Drug Administration (FDA) met with its Arthritis Advisory Committee to discuss Celltrion's Remsima, a...


Dec 09, 2015, 10:29 ET Physician Groups Urge Congress to Direct CMS to Adopt Unique Billing Codes for Biosimilars

On Wednesday, December 9, 2015, six groups representing a broad spectrum of physicians who prescribe biologics – Alliance for Patient Access,...


Oct 27, 2015, 03:14 ET Physician Groups Applaud FDA for Distinguishable Biologics Naming; But Argue that 'Random' Suffix Could Undermine Achievement

On Tuesday, October 27, 2015, eight groups representing a broad spectrum of biologics prescribers – Alliance for Patient Access, American Association ...


Sep 02, 2015, 07:00 ET Physician Groups Urge CMS: Follow FDA Lead on Unique Names for Biological Medicines

On Tuesday, September 1, 2015, six groups representing a broad spectrum of physicians who prescribe biologics – Alliance for Patient Access, American ...


Aug 27, 2015, 03:19 ET Biologics Prescribers Collaborative (BPC) Statement on FDA Draft Guidance entitled "Nonproprietary Naming of Biological Products"

Biosimilars are not generics and the Biologics Prescribers Collaborative (BPC) applauds the U.S. Food and Drug Administration (FDA) for recognizing...


May 21, 2015, 12:55 ET Physician Groups Urge FDA to Ensure Patient Safety With Greater Transparency in Biosimilar Labeling

Today, eight groups representing a broad spectrum of physicians who prescribe biologics – Alliance for Patient Access, American Association of...


Mar 26, 2015, 11:02 ET Patient Advocates, Physicians, Pharmacists Unite to Support Unique Biosimilars Naming Policy

On Tuesday, March 24, 2015, five advocacy groups representing a broad spectrum of physicians, pharmacists and patients – the American Autoimmune...